266 related articles for article (PubMed ID: 11384710)
1. Human immunodeficiency virus type 1-related nucleic acids and papillomavirus DNA in cervicovaginal secretions of immunodeficiency virus-infected women.
Spinillo A; Debiaggi M; Zara F; De Santolo A; Polatti F; Filice G
Obstet Gynecol; 2001 Jun; 97(6):999-1004. PubMed ID: 11384710
[TBL] [Abstract][Full Text] [Related]
2. Viral excretion in cervicovaginal secretions of HIV-1-infected women receiving antiretroviral therapy.
Debiaggi M; Zara F; Spinillo A; De Santolo A; Maserati R; Bruno R; Sacchi P; Achilli G; Pistorio A; Romero E; Filice G
Eur J Clin Microbiol Infect Dis; 2001 Feb; 20(2):91-6. PubMed ID: 11305478
[TBL] [Abstract][Full Text] [Related]
3. The effect of vaginal candidiasis on the shedding of human immunodeficiency virus in cervicovaginal secretions.
Spinillo A; Zara F; Gardella B; Preti E; Mainini R; Maserati R
Am J Obstet Gynecol; 2005 Mar; 192(3):774-9. PubMed ID: 15746671
[TBL] [Abstract][Full Text] [Related]
4. A longitudinal study of human papillomavirus DNA detection in human immunodeficiency virus type 1-seropositive and -seronegative women.
Vernon SD; Reeves WC; Clancy KA; Laga M; St Louis M; Gary HE; Ryder RW; Manoka AT; Icenogle JP
J Infect Dis; 1994 May; 169(5):1108-12. PubMed ID: 8169402
[TBL] [Abstract][Full Text] [Related]
5. Factors associated with nucleic acids related to human immunodeficiency virus type 1 in cervico-vaginal secretions.
Spinillo A; Debiaggi M; Zara F; Maserati R; Polatti F; De Santolo A
BJOG; 2001 Jun; 108(6):634-41. PubMed ID: 11426900
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of self-collected cervicovaginal cell samples for human papillomavirus testing by polymerase chain reaction.
Gravitt PE; Lacey JV; Brinton LA; Barnes WA; Kornegay JR; Greenberg MD; Greene SM; Hadjimichael OC; McGowan L; Mortel R; Schwartz PE; Zaino R; Hildesheim A
Cancer Epidemiol Biomarkers Prev; 2001 Feb; 10(2):95-100. PubMed ID: 11219778
[TBL] [Abstract][Full Text] [Related]
7. Serum immunoglobulin A response to human papillomavirus type 16 virus-like particles in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women.
Viscidi RP; Ahdieh-Grant L; Schneider MF; Clayman B; Massad LS; Anastos KM; Burk RD; Minkoff H; Palefsky J; Levine A; Strickler H
J Infect Dis; 2003 Dec; 188(12):1834-44. PubMed ID: 14673762
[TBL] [Abstract][Full Text] [Related]
8. High prevalence of oncogenic human papillomavirus in the genital tract of women with human immunodeficiency virus.
Volkow P; Rubí S; Lizano M; Carrillo A; Vilar-Compte D; García-Carrancá A; Sotelo R; García B; Sierra-Madero J; Mohar A
Gynecol Oncol; 2001 Jul; 82(1):27-31. PubMed ID: 11426958
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and risk factors for anal human papillomavirus infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women.
Palefsky JM; Holly EA; Ralston ML; Da Costa M ; Greenblatt RM
J Infect Dis; 2001 Feb; 183(3):383-91. PubMed ID: 11133369
[TBL] [Abstract][Full Text] [Related]
10. Comparison between vaginal tampon and cervicovaginal lavage specimen collection for detection of human papillomavirus DNA by the polymerase chain reaction. The Canadian Women's HIV Study Group.
Coutlée F; Hankins C; Lapointe N
J Med Virol; 1997 Jan; 51(1):42-7. PubMed ID: 8986948
[TBL] [Abstract][Full Text] [Related]
11. Cervical intraepithelial neoplasia and cervicovaginal shedding of human immunodeficiency virus.
Spinillo A; Zara F; Gardella B; Preti E; Gaia G; Maserati R
Obstet Gynecol; 2006 Feb; 107(2 Pt 1):314-20. PubMed ID: 16449118
[TBL] [Abstract][Full Text] [Related]
12. Incident high-grade squamous intraepithelial lesions in Senegalese women with and without human immunodeficiency virus type 1 (HIV-1) and HIV-2.
Hawes SE; Critchlow CW; Sow PS; Touré P; N'Doye I; Diop A; Kuypers JM; Kasse AA; Kiviat NB
J Natl Cancer Inst; 2006 Jan; 98(2):100-9. PubMed ID: 16418512
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus type 16 and immune status in human immunodeficiency virus-seropositive women.
Strickler HD; Palefsky JM; Shah KV; Anastos K; Klein RS; Minkoff H; Duerr A; Massad LS; Celentano DD; Hall C; Fazzari M; Cu-Uvin S; Bacon M; Schuman P; Levine AM; Durante AJ; Gange S; Melnick S; Burk RD
J Natl Cancer Inst; 2003 Jul; 95(14):1062-71. PubMed ID: 12865452
[TBL] [Abstract][Full Text] [Related]
14. Ano-genital human papillomavirus type 97 infection is detected in Canadian men but not women at risk or infected with the human immunodeficiency virus.
Landry ME; Salit IE; Rodrigues-Coutlée C; Money D; Rebbapragada A; Tinmouth J; Hankins C; Gorska-Flipot I; Archambault J; Franco EL; Coutlée F
Virol J; 2012 Oct; 9():243. PubMed ID: 23092191
[TBL] [Abstract][Full Text] [Related]
15. Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women.
Strickler HD; Burk RD; Fazzari M; Anastos K; Minkoff H; Massad LS; Hall C; Bacon M; Levine AM; Watts DH; Silverberg MJ; Xue X; Schlecht NF; Melnick S; Palefsky JM
J Natl Cancer Inst; 2005 Apr; 97(8):577-86. PubMed ID: 15840880
[TBL] [Abstract][Full Text] [Related]
16. A matched prospective study of human immunodeficiency virus serostatus, human papillomavirus DNA, and cervical lesions detected by cytology and colposcopy.
Eckert LO; Watts DH; Koutsky LA; Hawes SE; Stevens CE; Kuypers J; Kiviat NB
Infect Dis Obstet Gynecol; 1999; 7(3):158-64. PubMed ID: 10371475
[TBL] [Abstract][Full Text] [Related]
17. Presence of cell-free human immunodeficiency virus in cervicovaginal secretions is independent of viral load in the blood of human immunodeficiency virus-infected women.
Rasheed S; Li Z; Xu D; Kovacs A
Am J Obstet Gynecol; 1996 Jul; 175(1):122-9. PubMed ID: 8694037
[TBL] [Abstract][Full Text] [Related]
18. Factors predicting the persistence of genital human papillomavirus infections and PAP smear abnormality in HIV-positive and HIV-negative women during prospective follow-up.
Branca M; Garbuglia AR; Benedetto A; Cappiello T; Leoncini L; Migliore G; Agarossi A; Syrjänen K;
Int J STD AIDS; 2003 Jun; 14(6):417-25. PubMed ID: 12816671
[TBL] [Abstract][Full Text] [Related]
19. The impact of human immunodeficiency virus type 1 status on human papillomavirus (HPV) prevalence and HPV antibodies in serum and cervical secretions.
Marais DJ; Vardas E; Ramjee G; Allan B; Kay P; Rose RC; Williamson AL
J Infect Dis; 2000 Oct; 182(4):1239-42. PubMed ID: 10979925
[TBL] [Abstract][Full Text] [Related]
20. Evolution of cervical abnormalities among women with HIV-1: evidence from surveillance cytology in the women's interagency HIV study.
Massad LS; Ahdieh L; Benning L; Minkoff H; Greenblatt RM; Watts H; Miotti P; Anastos K; Moxley M; Muderspach LI; Melnick S
J Acquir Immune Defic Syndr; 2001 Aug; 27(5):432-42. PubMed ID: 11511819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
